Cejková J, Labský J, Vacík J, Michálek J, Brůnová B
Laborator histochemie oka, Ustav experimentální medicíny AV CR, Praha.
Cesk Slov Oftalmol. 1997 Oct;53(5):279-86.
UV absorbers developed by us are covalently bound in hydrophilic contact lenses. This is great advantage because UV absorbers cannot be diluted from contact lenses. In laboratory investigations and "in vivo" experiments it was found that contact lenses containing UV absorbents prevent the eye against the damaging effect of UV irradiation (UVA, UVB, UVC rays). The second new approach (mentioned in this paper) is the use of Hindered Amine Light Stabilizer (4-methakryloylamino-2,2,6,6-tetramethylpiperidine) covalently bound in the hydrophilic contact or therapeutic lenses--for the healing of the damaged eye. In laboratory measurements the cleavage of hydrogen peroxide (of various concentrations) by hindered amine light stabilizer was confirmed. In "in vivo" experiments it was examined histochemically and morphologically that Hindered Amines Light Stabilizer bound in contact lenses favourable influenced the healing of the damaged anterior eye segment of rabbits. The amount as well as enzyme activation (lysosomal hydrolases) of inflammatory cells was significantly reduced in the anterior eye segment. It is suggested that Hindered Amine Light Stabilizer reacts with reactive oxygen species (oxyradicals and hydrogen peroxide) present in the damaged anterior eye segment (e.g. released from inflammatory cells). During this reaction intermediate products appear and the resulting product is a nitroxide radical. All reaction products as well as resulting product are covalently bound in hydrophilic material. For the development and also evaluation of the efficacy of both new approaches perspective for the use in clinical ophthalmology, biochemical investigations and histochemical methods are employed. Enzyme histochemistry is very important for the evaluation of the efficacy of new therapeutic approaches "in vivo" and therefore the particular attention is devoted to it in this communication.
我们研发的紫外线吸收剂以共价键结合在亲水性隐形眼镜中。这是一个很大的优势,因为紫外线吸收剂不会从隐形眼镜中被稀释。在实验室研究和“体内”实验中发现,含有紫外线吸收剂的隐形眼镜可保护眼睛免受紫外线辐射(UVA、UVB、UVC射线)的伤害。本文提到的第二种新方法是使用受阻胺光稳定剂(4-甲基丙烯酰氨基-2,2,6,6-四甲基哌啶),它以共价键结合在亲水性隐形眼镜或治疗性镜片中,用于受损眼睛的愈合。在实验室测量中,证实了受阻胺光稳定剂对不同浓度过氧化氢的分解作用。在“体内”实验中,通过组织化学和形态学检查发现,结合在隐形眼镜中的受阻胺光稳定剂对兔子受损眼前节的愈合有有利影响。眼前节中炎症细胞的数量以及酶活性(溶酶体水解酶)显著降低。据推测,受阻胺光稳定剂与受损眼前节中存在的活性氧物质(氧自由基和过氧化氢,例如从炎症细胞中释放出来的)发生反应。在这个反应过程中会出现中间产物,最终产物是一个氮氧自由基。所有反应产物以及最终产物都以共价键结合在亲水性材料中。为了开发和评估这两种新方法在临床眼科中的应用前景、疗效,采用了生化研究和组织化学方法。酶组织化学对于评估新治疗方法在“体内”的疗效非常重要,因此在本通讯中对其给予了特别关注。